Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Splint vs Steroid Injection for DeQuervain's Tenosynovitis
NCT05165875Unknown
- Sponsor
- National University Hospital
- Start
- Jun 2022
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of triamcinolone acetonide in de Quervain's tenosynovitis (2 arms), sponsored by National University Hospital. Primary endpoints: Quick Disability of Arm, Shoulder, Hand at 6 months and Patients who have recovered from De Quervain's Tenosynovitis at 6 months. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
de Quervain's tenosynovitis
Beyond the preview
Go deeper on NCT05165875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05165875.